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REGULATION OF AMINOPEPTIDASE-N (CD13) AND FcfRIIb (CD23) EXPRESSION
BY IL-4 DEPENDS ON THE STAGE OF MATURATION OF
MONOCYTES/MACROPHAGES1
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IL-4 has multiple biologic activities and it has 
been shown to have effects on B and T lymphocytes, 
mast cells, NK cells, and monocytes. We studied the 
influence of IL-4 on the expression of cell membrane 
determinants, in particular aminopeptidase-N 
(CD13) and FceRIIb (CD23), on human peripheral 
blood monocytes. We compared the response of 
monocytes with the response of human alveolar 
macrophages and monocytic cell lines (U937 and 
THP1), as mature and more immature representa­
tives of the mononuclear phagocyte system, respec­
tively. A dose-dependent increase of the expression 
of CD13 Ag was observed when monocytes were 
cultured with IL-4. Kinetic analyses revealed that 
this induction was maximal after 2 to 3 days of 
culture and resembled the kinetics of IL-4-induced 
expression of FceRIIb on monocytes. This IL-4-in- 
duced increase was absent when monocytes were 
cultured with IL-4 and an anti-IL-4 antiserum. Con­
comitantly, an IL-4-induced increase in leucine-ami- 
nopeptidase activity could be observed. Northern 
blot analysis showed that incubation of monocytes 
with IL-4 induced a marked increase in CD13 mRNA. 
Alveolar macrophages also exhibited an increase in 
CD13 Ag expression when exposed to IL-4. Surpris­
ingly, IL-4 was unable to induce expression of 
FceRIIb on alveolar macrophages. U937 and THP1 
cells did not show an induction of CD13 Ag when 
cultured in the presence of IL-4, However, IL-4 did 
induce the expression of FceRIIb on both cell lines, 
suggesting the presence of functional IL-4R. Our 
data demonstrate that IL-4 increases the expression 
of CD13 Ag on monocytes. This IL-4-induced in­
crease can also be observed in more mature mono­
cytic cells such as alveolar macrophages, but is 
absent in immature cells such as U937 or THP1 
cells. This is functionally accompanied by an in­
crease in leucine-aminopeptidase activity and may 
be part of the general activation of monocytes/mac­
rophages by IL-4. In conclusion, the data suggest
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that IL-4 responsiveness, in particular the induction 
of CD13 Ag and FceRIIb expression, may be depend­
ent on the stage of maturation of monocytes/mac­
rophages.
Initially, IL-4 was described to act as a differentiation 
factor for resting B lymphocytes (1). Nowadays, IL-4 has 
been shown to have a variety of effects on different cell 
types. It may act as a  growth factor for activated T 
lymphocytes, thymocytes, NK cells (2-4), and  m ast cells 
(4, 5). It may modulate the expression of cell membrane 
determ inants, as FceRIIb (CD23) and class II MHC Ag on 
B lymphocytes (6 , 7) and  monocytes (8 , 9), and IL-2R 
(CD25) on B lymphocytes (10). Furtherm ore, it has been 
shown th a t IL-4 is able to stim ulate monocyte m aturation 
accompanied by modulation of m aturation m arkers as 
CD14 and RFD9 .3 In the  course of studying the influence 
of IL-4 on m onocytes/m acrophages we observed that IL- 
4 is also able to regulate the  expression of another mye­
loid Ag, CD 13 Ag.
Originally, the  cell m em brane glycoprotein (gpl50) de­
fined by CD13 mAb w as seen as a m arker for subpopu­
lations of hemopoietic cells (11-14). Currently, it is 
known to be present on m any nonhemopoietic tissues, 
including fibroblasts, the  in testinal and renal tubular 
epithelium (15, 16), and  on synaptic m em branes of the 
central nervous system  (17). As the glycoprotein has been 
identified as aminopeptidase-N (EC 3.4.11.2) (14, 18), it 
has been suggested th a t th is  cell m em brane enzyme may 
play a  role in modulating the activity of bioactive oligo­
peptides (19). In the knowledge th a t  the  effects of cyto­
kines on a  certain  cell type may depend on the m aturation 
or differentiation stage of the cell (2 0 » 2 1 ), we studied the 
influence of IL-4 on the expression of the CD 13 Ag on 
PBM4 as well as AM and  monocytic cell lines (U937 and 
THP1), which can  be regarded as more m ature and im­
m ature representatives of the m ononuclear phagocyte 
system, respectively. In th is  report, we demonstrate tha t 
IL-4 is able to induce a  strong increase in expression of 
the CD 13 Ag. This induction can be dem onstrated on 
PBM and AM, bu t not on U937 and THP1 cells.
3 Van Hal, P. Th. WM H. C. Hoogsteden, A. A. te  Velde, J . M. Wijkhuijs,
C. G. Figdor, and  C. Hilvering. IL-4-induced m aturation of monocytes/ 
macrophages is inhibited by glucocorticoids, S u b m itted  fo r  publication,
4 Abbreviations used in th is  paper: PBM, peripheral blood monocytes; 
AM, alveolar macrophages; LAP, L-leucine-aminopeptidase; BAL, bron- 
choalveolar lavage; PCR, polymerase chain reaction; GAM, goat anti­
mouse Ig antiserum .
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MATERIALS AND METHODS
Isola tion  o j  PBM . H um an  PBM were isolated from  500 ml blood 
from  healthy  volunteers a s  described e lsew here  (22). Briefly, m ono­
nuclear cells were separa ted  by density  cen trifuga tion  w ith  a  blood 
com ponent separator. Next, th e  m ononuclear cells w ere  frac tionated  
into lymphocytes and  m onocytes by cen trifugal é lu tria tion . The 
monocyte preparation  w as over 95% pure  a n d  con ta ined  m ore th a n  
98% viable cells as  judged by try p an  b lue exclusion. Lym phocytes 
and granulocytes constitu ted  less th a n  2% a n d  3% of th e  m onocyte 
preparation, respectively. Before an a ly s is  of th e  su rface  m em brane  
determ inan ts  the cells w ere w ashed  twice w ith  a  PBS solution (300 
mosmol; pH 7.8) supp lem ented  w ith  0.5% h ea t-in ac tiv a ted  BSA 
(Organon T eknika, Oss, T he  N etherlands).
Iso la tion  o f  AM. All lavage s tud ies  w ere approved  by th e  Medical 
E thics Committee of th e  E rasm u s U niversity /U niversity  H ospital 
Dijkzigt, Rotterdam . BAL w as perform ed in  hea lthy , nonsm oking  
volunteers a fte r prem edication  w ith th iaz in am iu m  a n d  local a n e s ­
thesia  using  a lidocaine (2%, w/v) spray. T h e  bronchoscope w as 
placed in wedge position in  th e  righ t m iddle lobe, a n d  fou r aliquots 
of 50 ml sterile saline solution w ere in fused  an d  asp ira ted  im m edi­
ately in a  siliconized specim en tra p  placed on m elting  ice. Im m edi­
ately a fte r collection th e  BAL fluid w as s tra in ed  th ro u g h  a  sterile  
nylon gauze to trap  large m ucous partic les, w h e rea fte r  th e  BAL cells 
were isolated by cen trifugation  a t  4°C a t  a  force of 400  X g. More 
th an  90% of the  BAL cells appeared  to be m acrophages a s  judged by 
May-Grünwald G iem sa sta in ing . Before ana ly sis  of th e  su rface  m em ­
brane de te rm inan ts  th e  cells were w ashed  twice w ith  PB S/0 .5% 
BSA,
Cell lines. U937 cells, originally described by S u n d stro m  and  
Nilsson (23) were m ain ta in ed  a t  concen tra tions  of 0 .25  to 1.0 X 108/  
ml in RPMI 1640 m edium  (Flow Laboratories, Irvine, UK) su p p le ­
m ented w ith  FCS (GIBCO, Paisley, UK) (10%), pen icillin  G sodium  
(102U/ml; Gist-Brocades, Delft, The N etherlands), a n d  strep tom ycin- 
sulfate (0.1 mg/ml; Biochrom KG, Berlin, Germany). THP1 cells (24) 
were obtained from th e  A m erican  Type C ulture Collection (Rockville, 
MD) and  m ain ta ined  according to th e ir  in s truc tio ns . In som e exper­
im ents, to  culture U 937 a n d  THP1 cells u n d e r  th e  sam e  conditions 
as PBM or AM, cells were m ain ta in ed  in  a  m odified Is cove’s m edium  
(see below).
C uïtu re  o f cells. Generally, U937 an d  THP1 cells w ere  cu ltu red  a s  
described above. In som e experim en ts  they  w ere cu ltu red  a s  PBM 
and AM. PBM and AM w ere cu ltu red  in a  m odified Iscove’s m edium  
(GIBCO) as  described previously (25), in w hich  BSA is replaced  by 
hum an  serum  album in  supp lem ented  w ith  2 % autologous hea t- 
inactivated serum . The cu ltu re  m edium  w as fo un d  to be endotoxin- 
free (defined as  less th a n  1.0  ng /m l of endotoxin  a s  quan tified  by 
the L im u lu s  amoebocyte lysate  assay). PBM (4 X 106/m l) an d  AM (1 -
2 X 106/ml) were cu ltured  a t  37°C, 5% C 0 2, a n d  100% hum id ity  in 
Teflon bags (Ja n sse n ’s MNL, S t.-N iklaas, Belgium) fo r 1 to  7 days. 
For detection of su rface  m em b ran e  d e te rm in an ts , cells w ere h a r ­
vested from the Teflon bags, a n d  cu ltu re  su p e rn a ta n t  w as  rem oved 
after centrifugation. Subsequently , th e  cells w ere w ash ed  tw ice w ith  
PBS/0,5% BSA/0.5% sodium  azide. T he  viability as  de term ined  by 
propidium iodide exclusion exceeded 85%. No s ig n ifican t d ifferences 
In th e  num bers of cells recovered a f te r  cu ltu re  In th e  p resence  of 
rIL-4 or anti-IL-4 an tise ru m  could be observed.
rIL-4, rIL-2, and  anti-IL-4 a n tise ru m .  H u m an  rIL-4 w as  a  gener­
ous gift of Dr. H. F. J .  Savelkoul (E rasm us U niversity , R otterdam , 
The Netherlands) an d  Dr. K. Arai (DNAX R esearch  Institu te , Palo 
Alto, CA), A polyclonal rab b it anti-IL-4 an tise ru m  w as  used. This 
an tiserum  blocks the  biologic activity  of IL-4, a s  h a s  been  described 
earlier (26). Hum an rIL-2 w as obtained  from  E urocetus (A m sterdam , 
The Netherlands).
D etection  of su r fa ce  m e m b ra n e  d e te rm in a n ts .  For im m unoflu ­
orescence sta in ing  of PBM a n d  AM th e  following mAb were used: 
CD 13 (9^0  (IgG2a), Dr. C. E. v an  der Schoot, A m sterdam , The 
Netherlands; My7 (IgGl) Coulter Clone, H ialeah, FL); CD23 
(Tül(IgGl), Biotest, Dreieick, G erm any; Leu-20 (IgGl), Bee ton  Dick­
inson, S an  Jose, CA). Isotype-m atched an tibod ies w h ich  w ere di­
rected aga inst idiotypic d e te rm in an ts  on a  B cell lym phom a cell line 
and did n o t reac t w ith  m onocytes w ere u sed  as control an tibodies. 
Fifty m icroliters of the  PBM or AM cell su sp en sio n  (2 X 106 cells/ml) 
were incubated  for 30 m in a t  4°C w ith  50 pi of one of th e  optim ally 
titrated mAb. Incubation w as perform ed in  96-well m icro tite r p lates. 
After th ree  w ashings the  cells w ere in cu b a ted  w ith  FITC-labeled 
GAM F(ab)2 (De Beer M edicals B. V., H ilvarenbeek, T he  N etherlands) 
for 30 m in  a t 4°C. A fter a n o th e r  th ree  w ash in g s  th e  cell pellets w ere 
resuspended for analysis of th e  fluorescence in ten s ity  by m e a n s  of 
a  FACScan (Becton Dickinson). The fluorescence in ten s itie s  of Ag 
expression are  expressed a s  a  ra tio  relative to  th e  backg round  fluo­
rescence in tensity  of cu ltu red  cells s ta in ed  w ith  an  isotype m atched  
antibody, w here a  value of 1.0  reflects fluorescence equ ivalen t to
background.
For immunologic s ta in ing  of U937 and  THP1 cells, the cell sus­
pension  (2 x  10®/ml) w as p reincubated  fo r 10 m in  a t  4°C with a  
solution of norm al ho rse  se rum  (final concen tra tion  5%, v/v). W ith­
out th is  p reincubation , in terp re ta tion  of th e  im m unologic stainings 
w ith  th e  re levan t mAb w as troublesom e because  of high aspecific 
binding. A fter th is  preincubation , th e  cells were s ta in ed  w ith the 
re levan t mAb as  described above for PBM a n d  AM.
All s tan d a rd  w ash ings w ere perform ed w ith  PB S/0 .5% BSA/0.5% 
sodium  azide.
P repara tion  o f  total cellu lar RN A a n d  N o rth ern  blot a n a ly s is . 
Total cellular RNA w as Isolated from  U937 and  THP1 cells and 
fresh ly  Isolated or cultured PBM an d  AM largely according to Chom- 
czynski an d  Sacchi (27). Briefly, cells w ere w ash ed  twice in PBS. 
Cells (5 -1 0  X 106) were homogenized w ith  0 .5  ml of solution D in a
1.5-ml E ppendorf tube. Sequentially, 50 >il of 2 M sodium  acetate 
(pH 4.0), 0.5 m l of w ater-sa tu ra ted  phenol, a n d  0.1 m l of chloroform 
were added to  th e  hom ogenate, w ith  thorough m ixing afte r the 
addition of each  reagent. The final su sp en sio n  w as cooled on ice for
15 m in. Sam ples were centrifuged a t  10 ,000  x  g  for 15 m in a t  4°C. 
T he  aqueous ph ase  w as tran sfe rred  to a  f re sh  tu b e  contain ing  0.5 
ml of Isopropanol, and  th e n  placed a t 4°C for a t  least 6  h to precipitate 
RNA. RNA w as recovered by cen trifugation  (10 ,000 x  g, 15 min, 
4°C), dissolved in  0.3 to 0.5 ml solution D, an d  precip itated  again 
w ith 1 volume of isopropanol. After cen trifugation  (10,000 x g, 15 
m in, 4 QC), th e  RNA pellet w as w ashed  in  0 .6  to 1.0 m l 75% ethanol 
and  eventually  dissolved in  25 to 50 ¿¿1 R N ase-free w ate r. Total RNA 
(1 0 - 2 0  /xg) w as separa ted  by electrophoresis in  a  1%-agarose gel (28), 
subsequen tly  vacuum  tran sfe rred  (29) onto a  nylon m em brane (NY-
13 N; Schleicher and  Schuell, Dassel, G erm any), fixed to the m em ­
b ra n e  w ith a  254  nm  UV cross-linker (S tra ta linker, S tratagene, La 
Jo lla , CA) an d  hybridized w ith th e  CD 13 probe, w h ich  w as labeled 
according to th e  Klenow-oligonucleotide m ethod  (30). Prehybridiza­
tion and  hybridization of RNA blots w ere perfo rm ed  as described 
elsew here (28). A fter hybridization the  b lo ts were w ashed  and  ex­
posed to Fuji NIF-RX films (Fuji Photo Film Co., Ja p a n )  with in ten ­
sifying screens.
P re p a ra t io n  of CD 13 cDNA probe. Total RNA w as extracted from 
AM, w hich  were obtained from  a hea lthy  individual. T he cDNA was 
syn thesized  w ith  reverse tran sc rip ta se  (31] a n d  subsequen tly  am ­
plified by using  the  PCR m ethod a s  described e lsew here  (32). For the 
PCR-mediated am plification, syn thetic  oligonucleotide prim ers were 
designed according to the  published CD13 cDNA sequence (18). The 
CD 13 upstream  prim er, aacggaa TTCC AG AGTGTGAGG AG ATGGTC, 
including an  aspecific 5 ' ta il (underlined) w ith  a n  EcoRI restriction 
site, and  th e  CD13 dow nstream  prim er, tg tg tc taga  CTTCACCCACTT- 
GATGTTGGCTT, including an  aspecific 5 ' ta il (underlined) w ith a 
X ba l  restric tion  site, were used in  th e  PCR. T he ob tained  562-bp 
PCR product w as electrophorized in  a  0 .7% -agarose gel, and  the 
b an d  con tain ing  th e  probe w as cu t out of th e  gel. T h e  probe w as 
electrophoretically recovered from  the  agarose gel frag m en t by using 
a  separa tion  cham ber (Biotrap; Schleicher a n d  Schuell) and cloned 
in  th e  pUC19 vector w ith  EcoRI and  X b a l  re s tric tio n  enzymes. 
Sequence analysis  of th e  cloned PCR frag m en t confirm ed th a t  the 
isolated probe rep resen ted  th e  expected CD 13 sequence.
F unctiona l a s s a y  f o r  a m in o p ep tid a se -N  ac tiv ity .  T he presence 
of am inopeptidase-N  activity on PBM, U 937, or T H P 1 cells was 
detected largely a s  described earlier (33). Briefly, th e  assay  was 
perform ed in wells (in triplicate) of 96-well m icro tite r plates. Cells 
w ere w ashed  twice in PBS. Fifty m icroliters of a  cell suspension  (1-
3 x 106 cells/ml) were incubated  w ith 50 ¡A of L - le u c in e - p - n i t r o a n i l id e  
(Sigma) (8.36 mM) for 30 m in  a t 37 °C. A fter th is  Incubation  enzy­
m atic  activity w as blocked by addition of 35 ¿tl of a 30%  (v/v) acetic 
acid solution, an d  the  increase  in specific ab so rb an ce  a t  405 nm  (as 
a  resu lt of accum ulation  of free p-n itroanilide) w as determ ined by 
using a  T itertek  M ultiskan  MCC p la te  read e r (I.C.N. Biomedicals B. 
V., A m sterdam , T he  N etherlands). A m inopeptidase-N  activity was 
expressed as th e  production of p -n itroan ilide  in  30 m in  by 10a cells 
(nm ol/30 m in x 106 cells).
RESULTS
CD 13 and  CD23 surface expression  on U937 cells, 
THP1 cells , PBM, and  AM. U937 cells cultured in me­
dium containing RPMI 1640 and 10% FCS do not express 
the CD 13 Ag. On the other hand, THP1 cells and freshly 
isolated PBM or AM clearly express th is  Ag (Fig. 1). The 
CD23 Ag could not be dem onstrated on either one of 
these cell sources (data not shown).
Influence of IL-4 on expression  o f  the CD13 Ag on
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TABLE I
Influence o f IL-4 on the expression  of the  CDJ3 Ag on blood 
monocytes can be blocked  by anti-IL-4 an ttserum a
Figure 1. Expression of the CD 13 Ag on human monocytic cell lines 
(U937 and THP1), freshly isolated PBM, and  AM. The fluorescence inten­
sity of 7500 cells was determined on a log scale with a FACScan. The 
left-hand  histogram in each of the four panels represents cells stained 
with an IgG2a control antibody and FITC-labeled GAM F(ab)a, whereas 
the right-hand histogram represents cells stained with Q20 (CD13) and 
FITC-labeled GAM F(ab}2.
Figure 2. Effects of IL-4 on the expression of the CD13 Ag on blood 
monocytes. Cells were stained with Q20 (CD 13) and FITC-labeled GAM 
F(ab)a either directly after isolation (B), or after a culture period of 3 days 
in modified Iscove’s medium without (C) or with (D; bold histogram) 100 
U IL-4/ml. Histogram A  represents monocytes stained with an IgG2a 
control antibody and FITC-labeled GAM F(ab)2. Fluorescence intensity of 
7500 cells was determined on a log scale with a FACScan. A representa­
tive experiment out of seven is shown.
hum an monocytes . Highly purified PBM were cultured 
for 3 days. As compared with the expression directly after 
isolation, the expression of the CD 13 Ag w as enhanced 
after culture (Fig. 2). This increase was consistently seen 
in all our experiments (n = 7). It could only partially be 
explained by an increase in cell size as there was only a  
limited rise in forward light scatter signal. Besides th is  
spontaneous increase in CD 13 Ag expression upon cul­
ture, IL-4 caused a considerable fu rther increase (Fig. 2). 
Compared with the control cultures, IL-4 induced a 2- to
3-fold further increase in CD13 Ag expression. This fu r­
ther increase was dependent on the concentration of IL- 
4 (maximal increase was found a t a concentration of 50 
U IL-4/ml) (data not shown) and could be blocked by the 
anti-IL-4 antiserum, adding proof to the  specificity of the  
induction (Table I). PBM cultured in the  presence of both
Days of 
Culture Medium
Medium + IL-2 
(1 0 0 0  U / th1)
Medium + IL-4 
(100 U/ml)
Medium + ÎL-4 
(100 U/ml) + 
anti-IL*4
0 17.3b 17.3 17.3 17.3
3 35.2 36.7 94.8 34.3
a Freshly isolated monocytes or monocytes cultured either in mock- 
medium or in the presence of IL-2, IL-4 alone, or both IL-4 and  anti-IL-4 
were labeled with Q20 (CD13) and F ITC-conjugated GAM F(ab)2. A repre­
sentative experiment out of seven is shown.
*Data are expressed as relative fluorescence, i.e., the ratio between 
the mean linear fluorescence intensity of cells labeled with the relevant 
antibody and the m ean fluorescence Intensity of cells labeled with the 
isotype-matched control antibody.
Figure 3. Kinetics of the effect of IL-4 on the m em brane expression 
of CD13 Ag on hum an monocytes. Monocytes were cultured without (O) 
or with (•) IL-4 (100 U/ml). Fluorescence intensity of 7500 cells was 
determined with a  FACScan. On the ordinate Is given the relative fluores­
cence, calculated as described in the footnote to Table I. Data of a 
representative experiment out of three are shown.
IL-4 and the  anti-IL-4 an tiserum  exhibited the  same 
spontaneous bu t small up-regulation of CD 13 Ag as PBM 
cultured in mock-medium (Table I). In addition, IL-2 did 
not induce a  fu rther increase in CD13 Ag expression 
(Table I). Because IL-4 is known to have long lasting (MHC 
class II Ag (9), CD14 Ag,3 RFD9 Ag3) and  tran s ien t (CD23 
Ag (8 )) effects on the expression of cell m em brane deter­
m inants, we studied the  kinetics of the influence of IL-4 
on CD13 Ag expression.
In fluence o f IL-4 on the  expression  o f  the  CD 13 Ag on 
h u m a n  m onocytes during a  culture period o f  7 days. 
A n  up-regulation of the  determ inant recognized by CD 13 
w as already observed after 1 day of culture (Fig. 3 and 
Table II), This increase w as observed in medium without 
IL-4, bu t w as m uch more substan tia l w hen PBM were 
cultured with IL-4. Maximal induction of CD13 Ag was 
seen after 2 to 3 days of culture. Thereafter, expression 
of CD 13 Ag diminished. However, even after 7 days of 
culture expression of CD 13 Ag w as higher than the 
expression on freshly isolated PBM. During the whole 
culture period, PBM cultured in the presence of IL-4 
exhibited a higher expression of CD 13 Ag th an  PBM 
cultured in medium w ithout IL-4.
We compared the tran s ien t induction of CD 13 Ag by 
IL-4 w ith the  know n tran s ien t induction of FceRIIb 
(CD23) and the  IL-4-induced down-regulation of CD 14 
Ag3 (Table II). Also in our experim ents we observed a 
tran s ien t induction of FceRIIb by IL-4. Maximal expres­
sion w as seen after 2 to 3 days of culture, coinciding with 
the  m axim al induction of CD 13 Ag expression. In con­
tras t, down-regulation of CD 14 Ag by IL-4 seemed to be 
a  long lasting phenom enon. Expression of CD 14 Ag was
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TABLE II
Time course of the influence of IL-4 on the expression of the CD 13,
CD 14, and  CD23 Ag on hum an blood m onocytesa
Days of 
Culture
Medium Medium + IL-4 (100 U/ml)
CD13 CD14 CD23 CD13 CD 14 CD23
0 5.8b 9.4 1.1 5.8 9.4 1.1
1 30.0 11.0 1.1 75.7 7.6 3.6
2 56.2 _c 1.0 192.8 1.8 6.6
3 47.8 — 155.1 —
5 22.5 10.4 1.0 56.7 1.0 2.1
6 20,2 7.0 1.0 31.6 1.1 1.2
7 11,4 5.1 0.8 23.9 1.3 1.1
a Monocytes were labeled with either Q20 (CD13), or UCHM1 (CD14), 
or Tul (CD23), followed by labeling with FITC-conjugated GAM F(ab)2 
either directly after isolation or after 1, 2, 5, 6 , or 7 days of culture with 
or without IL-4. A representative experiment out of three is shown.
b Data are expressed as relative fluorescence, calculated as described 
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Figure 4. Time course of the influence of IL-4 on the membrane 
expression of the CD 13 and CD23 Agon the monocytic cell line U937 and 
human alveolar macrophages. Cells were cultured either without (O) or 
with (•) 30 U IL-4/ml. Fluorescence intensity of 7500 cells was deter­
mined with a FACScan. On the ordinate is given the relative fluorescence, 
calculated as described in the footnote to Table I. Both data of U937 cells 
and macrophages represent one representative experiment of four.
almost completely lost after 2  days of culture in the 
presence of IL-4 and reexpression was not observed even 
after 7 days of culture. This indicates th a t IL-4 has 
transient and sustained effects. The transien t IL-4 ef­
fects probably reflect a  tem porary change in state of 
activation, whereas the long lasting effects may regard 
monocyte m aturation .3
As there are indications th a t the m aturation/differen­
tiation state of the cell may determ ine its susceptibility 
to influences of IFN~y or TNF-a (21), we investigated 
whether more m ature and im m ature representatives of 
the mononuclear phagocyte system respond to IL-4 in the 
same way as PBM.
Influence of IL-4 on the  expression  of the CD13 Ag on 
U937 cellsf THP1 cells, and  h u m a n  AM. U937 cells are 
known to express FceRIIb upon culture in the  presence 
with IL-4 (34). In our studies, we could also dem onstrate 
induction of a weak expression of FceRIIb by IL-4. This 
induction appeared to be transien t and was maximal 
after 3 days of culture. On the other hand, culture with 
IL-4 did not result in induction of CD 13 Ag (Fig. 4).
Neither culture in RPMI 1640 supplemented with 10% 
FCS and rIL-4 nor culture in modified Iscove’s medium 
supplemented with rIL-4 revealed induction of CD 13 Ag 
expression on U937 cells. Although on PBM CD13 Ag 
expression increased after only 1 day of culture with 30 
U IL-4/ml, induction of CD13 Ag expression on U937 
cells could not be detected even after 2 to 3 days of culture 
with 100 U IL-4/ml.
Human AM were found to express CD 13 Ag constitu- 
tively (Fig. 1). Upon culture, th is expression increased, 
and th is increase appeared to be maximal after 2 to 3 
days of culture (Fig. 4). With respect to the kinetics of 
increase in CD13 Ag expression during culture, PBM and 
AM appeared to be comparable. Moreover, IL-4 caused a 
fu rther increase in CD 13 Ag expression similar to that 
observed in PBM (Figs. 4  and 5). Maximal expression was 
observed after 2 to 3 days of incubation. After 4 to 5 
days, expression of CD 13 Ag on AM cultured with IL-4 
was almost identical to the expression on AM cultured 
without IL-4. However, expression after 4 to 5 days of 
culture was still higher th an  expression on freshly iso­
lated AM. These data  indicate that, besides the basal 
culture-induced increase in CD 13 Ag expression, IL-4 
induced an  additional transien t up-regulation of CD 13 
Ag on AM. On the other hand, IL-4 was unable to induce 
FceRIIb expression on AM (Fig. 4). Because an IL-4-in- 
duced increase of CD 13 Ag expression was observed only 
in constitutively CD13+ cells (PBM and AM) and not in 
constitutively CD13" cells (U937), we examined whether 
IL-4 was able to modulate expression on THP1 cells, 
which are, like U937 cells, immature monocytic cells but 
constitutively express CD13 Ag. In THP1 cells, expression 
of CD13 Ag was not changed, neither when these cells 
were cultured in RPMI 1640 supplemented with 10% FCS 
and rIL-4 nor when they were cultured in modified Is- 
cove’s medium supplemented with rIL-4 (data not 
shown}. On the other hand, THP1 cells were able to 
respond to IL-4, ju s t as expression of FceRIIb was induced 
on U937 cells (data not shown).
IL~4 increases LAP activity of hum an monocytes . To
10° 10 102 103 10'
Figure 5, Effects of IL-4 on the expression of the CD 13 Ag on alveolar 
macrophages. Cells were stained with Q20 (CD 13) and FITC-labeled GAM 
F(ab]2 either directly after Isolation (B), or after a culture period of 2 days 
in modified Iscove’s medium without (C) or with (D; bold histogram) 30 U 
IL-4/ml. Histogram A represents macrophages stained with an IgG2a 
control antibody and FITC-labeled GAM F(ab)2. Fluorescence intensity of 
7500 cells was determined on a log scale with a FACScan, A representa­
tive experiment out of three is shown.
IL-4 REGULATES EXPRESSION OF CD 13 AND CD23 ON MONOCYTES/MACROPHAGES 1 3 9 9
determine whether the IL-4-induced up-regulation of 
CD13 Ag reflects a functional increase in aminopeptidase 
activity of PBM, we studied whether IL-4 enhanced the 
capacity of PBM to degrade L-leucine-p-nitroanilide. PBM 
cultured for 2 days showed a decrease In LAP activity 
compared with freshly isolated PBM, despite an  increase 
in CD 13 Ag membrane expression (Table III). These ap­
parent contradicting data may be explained by prelimi­
nary observations tha t also other m em brane enzymes 
(which may be down-regulated upon culture) can display 
peptidase activity comparable to CD 13 Ag (Dr. E. Fava- 
loro, personal communication). On the other hand, PBM 
cultured for 2 days with IL-4 exhibited a higher activity 
to degrade L-leucine-p-nitroanilide th a n  PBM cultured 
without IL-4 (Table III). These data  add proof th a t IL-4 is 
able to increase the functional activity of PBM to degrade 
L-leucine-p-nitroanilide. U937 cells, which do not express 
CD 13 Ag, exhibited a 20-fold lower capacity to degrade l- 
leucine-p-nitroanilide, whereas THP1 cells, which do ex­
press CD 13 Ag, had a capacity comparable with freshly 
Isolated PBM (data not shown). To obtain more direct 
evidence for the influence of IL-4 on the expression of 
CD 13 Ag and because IL-4 has been described to induce 
CD23 mRNA (35), we investigated the effect of IL-4 on 
CD 13 mRNA.
IL-4 increases the expression oj CD 13 mRNA . Total 
RNA was isolated from freshly isolated hum an PBM and 
PBM cultured for 2 days with or without IL-4. Total RNA 
was separated by electrophoresis and hybridized with a 
32P-labeled CD 13 cDNA probe. The results in Figure 6 
show that IL-4 induced a strong increase in the level of 
CD13 mRNA in PBM (Fig. 6 , lane  2). PBM cultured for 2 
days in mock-medium exhibited a small, spontaneous 
increase in the level of CD13 mRNA (Fig. 6 , lane 3), CD 13 
mRNA was not detectable in U937 cells, whereas the 
level of CD 13 mRNA in THP1 cells resembled the level in 
freshly isolated PBM and AM.
DISCUSSION
Initially, it was thought tha t a certain cytokine directed 
its single activity at one particular cell type. Nowadays, 
it is generally accepted that different cytokines can reg­
ulate the same immune activity, th a t a single cytokine 
may effect a multitude of activities, and tha t these activ­
ities may be directed at multiple cell types (36-39). More­
over, recent reports describe th a t  the responsiveness of 
a  certain cell type to a particular cytokine may depend 
on the stage of m aturation/differentiation of tha t cell 
type (21). IL-4 was originally described as a B cell growth 
factor, but is now also known to influence T lymphocytes, 
NK cells, and monocytes as well. Some of the m any
effects of IL-4 can also be brought about by other cyto­
kines (38, 39). The data presented here widen the range 
of activities of IL-4 and show th a t IL-4 responsiveness of 
monocytic cells depends on the ir stage of m aturation.
It has been reported by different investigators th a t IL- 
4 is able to modulate the expression of several cell surface 
determ inants. IL-4 is able to induce a tran sien t expres­
sion of FeRIIb (CD23) on PBM (8) and monocytic cell lines
(35). Furtherm ore, IL-4 enhances the expression of class 
II MHC Ag on PBM (9) and  AM (P. Th. W. van Hal, 
unpublished observations), down-regulates th e  expres­
sion of FcyR on PBM (40), and modulates m aturation 
m arkers on PBM.3 Our data  indicate th a t  IL-4 is also able 
to increase the expression of the CD 13 Ag. This increase 
appears to be transien t and  resem bles the  kinetics of IL-
4-induced FceRIIb expression. Furtherm ore, IL-4 in ­
creases the level of CD 13 mRNA and raises the  capacity 
to degrade L-leucine-p-nitroanilide. Besides these IL-4- 
induced increases, a small and spontaneous up-regula- 
tion of CD 13 Ag w as observed after culture of monocytes 
in mock-medium. It is unlikely th a t  th is spontaneous up- 
regulation is due to contam inating am ounts of IL-4, as 
culture of PBM in the presence of both IL-4 and  the anti- 
IL-4 an tiserum  reduced CD 13 Ag expression to the levels 
of PBM cultured in mock-medium, and  not to the levels 
of freshly isolated PBM. Furtherm ore, th is spontaneous 
increase could not be explained by serum  com ponents or 
adherence, as culture of PBM in serum -free medium gave 
sim ilar results (data no t shown), and PBM were cultured 
under nonadheren t conditions in Teflon bags, respec­
tively. As culture of PBM in mock-medium induces also 
a spontaneous increase in MHC class II expression (9), it 
appears th a t in our system  activation takes place, most 
likely because of medium components, e.g., low levels of 
LPS. The spontaneous increase in CD 13 Ag expression 
m ay be part of th is activation.
To our knowledge th is is the  first report on IL-4-induced 
expression of CD 13 Ag, although recently Rohrbach and 
Conrad (41) reported th a t leucine-aminopeptidase (EC 
3.4.11.2 and  identical to CD 13 Ag) activity in cultured 
PBM w as enhanced by th e  presence of T lymphocytes. 
They found th a t the majority of increase occurred during 
the  first day of culture, w hereas they saw  a fu rther slight 
increase up until day 6 of culture. Although they did not 
confirm their da ta  with im m unofluorescence staining for 
CD 13 Ag and did not speculate on the m echanism  by 
w hich leucine-am inopeptidase activity w as increased, we 
th in k  th a t the ir results can  be explained by the produc­
tion of IL-4 by activated T lymphocytes, w hich is consist­
ent w ith our own results.
Surprisingly, induction of CD 13 Ag by IL-4 could not
TABLE III
influence of IL-4 on the LAP activity o f hum an monocytes, related to the  expression of the CD13 A ga
Experiment 1 Experiment 2
Days of 
Culture Medium Medium -f IL-4 Medium Medium 4* IL-4
LAP CD13 LAP CD13 LAP CD13 LAP CD13
0 231b 3.8° 231 3.8 171 5.1 171 5.1
2 108 17.0 229 158.2 108 14.1 199 189.4
a Monocytes were assayed for their LAP activity directly after isolation and after 2 days of culture with or w ithout 100 
U of IL-4/ml. Monocytes of the same donor were also labeled with Q20 and FITC-conjugated GAM F(ab)2 directly after 
isolation and after two days of culture with or without 100 U IL-4/mi.
b Data represent enzymatic activity and are expressed as the  rate of accumulation of p-nitroanilide, nm ol/30 min x 108 
cells.
c Data are expressed as relative fluorescence, calculated as described in the footnote to Table I.
















Figure 6. Induction of CD13 mRNA by IL-4 in hum an PBM, Total RNA 
was isolated from freshly isolated monocytes (lane 1), and from cells 
cultured for 2 days in the presence (lane 2 , +) or absence [lane 3, - )  of 
IL-4. Each of these three lanes contains 10 ¿ig of total RNA. Lanes 4 to 9 
contain 1, 2, 4, 8 , 16, and 32 jug of RNA from the  CD13+ cell line THP1, 
respectively. Lanes 10 and 11 contain 10 and 20 fig of RNA from the 
CD13" cell line U937, respectively. Lane 12 contains 5 fig of total RNA 
from freshly isolated AM. RNA was separated by electrophoresis, tran s­
ferred onto a nylon membrane, and hybridized with the 3aP-labeled CD13 
cDNA probe (upper panel). The lower panel shows ethidtumbromtde 
staining of the gel after electrophoresis to visualize loading per lane.
be achieved on im m ature monocytic cell lines, such as 
U937 and THP1 . We confirmed the earlier observations 
that IL-4 is able to induce FceRIIb expression on these 
cell lines. Therefore, unresponsiveness to IL-4 concern­
ing the induction of CD 13 Ag cannot be explained as a 
result of absence of functional IL-4R. On the other hand, 
AM, ju s t like PBM, increased their expression of CD 13 
Ag upon culture with IL-4. AM and PBM constitutively 
express CD 13 Ag, w hereas U937 cells lack th is Ag. There­
fore, one could speculate tha t IL-4 is only able to enhance 
actual expression of CD 13 Ag, although it is unable to 
induce expression on a CD13" cell type. If so, one would 
expect an  increase in expression of CD 13 Ag on THP1 
cells, which are constitutively positive for th is m arker, 
upon culture with IL-4. This, however, could not be dem ­
onstrated in our experiments. We therefore propose, th a t 
immature monocytic cells are unable to enhance CD13 
Ag expression upon culture with IL-4 despite the presence 
of functional IL-4R, and th a t the  ability to enhance CD13 
Ag expression after culture with IL-4 is acquired only 
upon maturation. On the other hand, it may also be 
possible tha t the  cell lines in question are  unable to 
up-regulate CD 13 Ag because of cell line-related prop­
erties other th an  im m aturity, e.g., altered sta te  of 
(de)activation.
An analysis of the literature showed th a t others also 
indicated that cytokine effects are variable depending on 
the cell type and/or the stages of differentiation. Kawabe 
et al. (34) mentioned th a t CD23 Ag could be up-regulated 
by IL-4 on normal B lymphocytes, bu t not on EBV-trans- 
formed B lymphoblastoid cell lines. Littman et aL (39) 
found th a t IL-4 did not stimulate undifferentiated HL-60 
cells to produce C2. However, when these cells were first
preincubated with vitamin D3 to induce monocytic differ­
entiation, they did produce C2 in response to IL-4. Re­
cently, W atanabe and  Jacob (21) demonstrated that TNF- 
a enhanced IFN-7 -induced MHC class II Ag expression in 
immature cells, such as U937 cells, whereas TNF-a had 
no effect on IFN-7 -induced MHC class II Ag expression in 
12-O -tetradecanoylphorbol-13-acetate-d ifferen tiated  
U937 cells. They also proposed th a t cytokine effects de­
pend on the m aturation stage of cells.
As IL-4 was able to induce FceRIIb expression on U937 
cells and PBM, we were surprised to see that it was unable 
to induce expression on AM. Although there are some 
reports showing expression of FceRIIb on AM (42, 43), it 
seems unlikely from our study th a t IL-4 plays a decisive 
role in this expression, a t least as an isolated factor. 
Bieber et al. (44) were able to induce FceRIIb on a subpop­
ulation of hum an epidermal Langerhans cells, but they 
used IL-4 in a high dose (1000 U/ml) and in combination 
with IFN-7  (1000 U/ml). However, it should be empha­
sized th a t we cannot exclude the  possibility that IL-4 in 
combination with other cytokines may be able to induce 
FceRIIb on AM, or th a t IL-4 is able to induce FceRIIb on a 
small (immature) subpopulation of AM, as FACScan 
analysis is inappropriate for detecting positive subpopu­
lations constituting less then  1- 2 % of the total cell pop­
ulation. Nevertheless, virtually the whole population of 
U937 cells and PBM express FceRIIb after culture with 
IL-4, whereas virtually the whole population of AM does 
not respond. These findings suggest that upon m atura­
tion the ability to express FceRIIb during culture with IL- 
4 is lost. This notion is supported by the findings of Te 
Velde et al. (45), who demonstrated that IL-4-matured 
PBM do not reexpress FceRIIb upon renewed addition of 
IL-4 on day 4 of culture.
In conclusion, our findings reveal a new property of IL- 
4, namely an  up-regulation of the expression of CD13 Ag 
on monocytic cells. As the CD 13 Ag represents amino- 
peptidase-N activity, th is up-regulation may be part of an 
IL-4-induced activation of monocytic cells. Furthermore, 
our findings provide a  model to explain the paradoxical 
effects of cytokines on a certain cell type. Positive or 
negative effects of a cytokine on a single cell type may be 
related to differences in stage of maturation, differentia­
tion, or activation.
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